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Background. The benefits of breastmilk are well described, yet the mechanistic details related to 
how breastmilk protects against acute and chronic diseases, and optimizes neurodevelopment 
remain largely unknown. Recently, breastmilk was found to contain stem cells that are thought to 
be involved in infant development. 
Purpose. The purpose of this review was to synthesize all available research involving the 
characterization of breastmilk stem cells to provide a basis of understanding for what is known 
and what still needs further exploration. 
Methods/Search Strategy. The literature search was conducted between August and October 
2015 using CINAHL, PubMed, and reference list searching. Nine studies addressed 
characterization of human breastmilk stem cells.  
Findings/Results. Five research teams in four countries have published studies on breastmilk 
stem cells. Current research has focused on characterizing stem cells in full-term breastmilk. The 
amount, phenotype, and expression of breastmilk stem cells is known to vary between mothers 
and they have been able to differentiate into all three germ layers (expressing pluripotent 
characteristics). 
Implications for Practice. There is much to learn about breastmilk stem cells. Given the 
potential impact of this research, healthcare professionals should be aware of their presence and 
ongoing research to determine benefits for infants.  
BREASTMILK STEM CELLS 
Implications for Research.  Extensive research is needed to further characterize stem cells in 
breastmilk (full-term and preterm), throughout the stages of lactation, and most importantly, their 
role in the health of infants, and potential for use in regenerative therapies.  
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BREASTMILK STEM CELLS 
Background 
The benefits of breastmilk are well described, yet the mechanistic details related to how 
breastmilk protects against chronic diseases and optimizes neurodevelopment remain unknown. 
Recently, breastmilk was found to contain stem cells which may be a source for cellular 
interactions or secreted products that foster childhood health. As such, they have been 
hypothesized to be involved in infant growth and development.1-3 The presence of breastmilk 
stem cells provides an opportunity to consider new pathways for describing the mechanisms that 
underlie the significance of breastmilk in early life, and the potential to explain how breastmilk 
may positively influence childhood and adult health, especially in the preterm infant. See Table 
1 for definitions of words used throughout this manuscript.  
Breastmilk is Different for Full-term and Preterm Infants 
Breastmilk is recognized as the ideal feeding type for all infants due to its known 
nutritional and immunological properties.4 As research methods advance, our knowledge of the 
science and mechanisms supporting the benefits of breastmilk continues to grow. Researchers 
have recognized that breastmilk is individualized for each mother-infant dyad to meet specific 
needs of the infant based on a variety of factors such as infant illness, gestation, post-natal age 
and gender.1,5-7 For example, the breastmilk of mothers whose infants have active infections is 
known to contain increased numbers of infection-fighting white blood cells.6 Mothers whose 
infants are born prematurely are also known to have breastmilk with different composition (e.g. 
micro and macronutrients) than mothers of full-term infants.8-11 Additionally, lactation research 
in Holstein cattle have found that more milk is produced for female calves than males.5 
Considering the hypothesis that breastmilk stem cells are involved in infant growth and 
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development, and the known variability in other aspects of breastmilk composition, suggests that 
there may be differences in the stem cell content between full-term and preterm milk.  
 Overview of Stem Cells 
 Human embryonic stem cells (hESCs) are derived from blastocysts (a 3 to 5 day old 
embryo).12 These stem cells are the most versatile because they can form any type of cell and 
tissue within the body due to their normal function to grow from embryo to fetus (ectoderm, 
mesoderm, and endoderm are the three germ layers).12 Once stem cells are directed to a 
particular lineage, our body uses them to regenerate cells and tissues as part of normal growth 
and repair. At this stage they typically cannot deviate from their assigned cell type. For example, 
adult cells are typically only able to replicate into the specific cell or tissue lineage they are from 
(e.g. skin cells can only replicate into other skin cells). However, scientists have found ways to 
induce pluripotency (ability to replicate into other cell lines) among some adult cells for possible 
use in regenerative medicine.12  
Stem Cells in Breastmilk 
Breastmilk stem cells were first described in 2007 by a team of scientists in Australia.13 
This initial study analyzed breastmilk from mothers of full-term infants and found that nestin 
positive stem cells were present.13 Nestin is a well-known marker for neural, bone marrow, 
pancreatic, and epithelial stem cells.13-18 Further research indicated that breastmilk stem cells 
exhibit characteristics of pluripotent stem cells.19 This finding indicates that like hESCs, they 
have the potential to differentiate into all of the cells and tissues in different body organs.1,19 
 Stem cell research from sources other than breastmilk provides a variety of uses in 
regenerative medicine. Currently, stem cells are used in cell replacement therapies, cell renewal, 
and many ongoing research trials that seek to expand the use of stem cells in the prevention and 
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treatment of disease.20 The potential of stem cells is immense and finding them within breastmilk 
promises a new mechanism of action to consider when exploring how to garner and allocate their 
beneficial properties. Many of the teams who have studied breastmilk stem cells have agreed that 
these cells may have the potential to be used in regenerative medicine and 
bioengineering.2,13,19,21-25 Researchers hypothesize that following ingestion, breastmilk stem cells 
interact with the infant to promote tissue homeostasis, development, and overall regeneration.2 
Breastfeeding allows maternal cells (e.g. leukocytes) to spread throughout the infant’s body in a 
process known as microchimerism.26,27 This mechanism prompted scientists to explore similar 
actions of breastmilk stem cells, and using mouse models they found that ingested breastmilk 
stem cells survive the gastrointestinal tract and spread throughout the body where they are then 
found as differentiated cells within different organs of the mouse pup.28,29 This finding has the 
potential to explain some of the short and long-term effects attributed to being breastfed as an 
infant but further investigation is needed to substantiate this linkage. Further understanding of 
breastmilk stem cells shows promise in at least two different areas. The first of these is the 
potential that breastmilk stem cells are actively involved in supporting infant growth and 
development (both short and long term) through mechanisms that are not yet fully understood. 
For example, it is not fully understood how breastmilk ingestion in early life can decrease 
disease later in life (clear mechanistic linkages do not exist). These mechanisms might be 
explained through breastmilk stem cells. The second is the possibility that breastmilk stem cells 
could be used in regenerative medicine to replenish and restore damaged tissues.  These findings 
could be particularly important for preterm infants, whose vulnerabilities (e.g. underdeveloped 
organs and high risk for morbidities) make their needs particularly great.  
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Laboratory Techniques 
 Breastmilk stem cells have been analyzed using various methods. The methods to 
characterize breastmilk stem cells provide information on the cell phenotype and expression, 
amount of cells present, and the viability of cells.  Some of the most common methods of 
analysis include immunofluorescence, quantitative reverse transcription polymerase chain 
reaction (qRT-PCR), and flow cytometry. Each of these methods works to identify whether 
certain markers are expressed in a cell population and use different mechanisms to tag these 
genes of interest (See Table 1). Typically breastmilk is collected fresh and then brought directly 
to the laboratory for processing. Scientists can then examine the freshly expressed breastmilk for 
the presence of specific genes, which are likely most representative of the cells that are ingested 
by the infant if the breastmilk had been used in enteral feeding. The breastmilk can also be 
cultured, which is a process of extracting cells from breastmilk and placing them in a culture dish 
with specific growth medium to encourage cellular growth. Many scientists will grow the cells 
until they are confluent, which means that they fill the plate they are growing on, and will then 
proceed with analyzing these cells to determine the presence of different stem and other cell 
characteristics.  
Purpose 
As the scientific evidence accumulates regarding breastmilk stem cells, scientists have 
hypothesized about their potential to influence infant health. There are published reviews on the 
implications of breastmilk stem cells,1,3 however, despite the mounting literature, no known 
publications provide a concise accumulation of all original articles on human breastmilk stem 
cell research. The purpose of this review was to synthesize all available original research focused 
on characterizing human breastmilk stem cells. 
BREASTMILK STEM CELLS 
Methods/Search Strategy 
The literature search was conducted between August and October 2015 and no 
restrictions were placed on year of publication. The electronic databases of PubMed and the 
Cumulative Index for Nursing and Allied Health Literature (CINAHL) were searched for 
potential articles using the search terms of Human milk, Breastmilk, Stem Cells, and limited to 
research on human breastmilk.  
Study Selection and Data Collection Process 
Articles were evaluated to determine if they analyzed human breastmilk for the presence 
of stem cells. The outlined search strategy resulted in 12 articles from CINAHL and 29 articles 
from PubMed (see Figure 1) for a total of 41 publications examined for the review. After title 
and abstract review 29 articles were eliminated for not meeting inclusion criteria (original 
research on breastmilk stem cells) – leaving 12 articles for full manuscript review. Thorough 
evaluation of those 12 studies resulted in the elimination of three studies due to their lack of 
analyzing human breastmilk samples for stem cells (they were focused on other aspects of 
breastmilk cells, and transplant tolerance after receiving breastmilk). The remaining nine studies 
were extensively reviewed for findings on characterization of breastmilk stem cells. The 
reference lists of included articles were reviewed for additional eligible studies, but no new 
studies were identified through this method. Additionally, we present our research focused on the 
preterm infant, a first in this line of research.   
Findings/Results 
Nine studies were reviewed that specifically addressed breastmilk stem cells and are 
summarized in Table 2. The years that studies were published ranged from 2007 until 2015 
(Figure 2), and the existing research evolved primarily from four large research teams in four 
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countries (Australia, Singapore, Iran, India). One additional study of our team in the United 
States is also presented in Table 2 because of its focus on the preterm infant. 
Breastmilk Contains Stem Cells 
Cregan et al. were the first to investigate the presence of stem cells in breastmilk in 
2007.13 These scientists evaluated breastmilk for the presence of a mammary stem cell marker, 
mature epithelial markers, and nestin (a multipotent stem cell marker). Their findings indicated 
that breastmilk contains nestin positive cells which indicates that there are multipotent stem cells 
in breastmilk. This groundbreaking work sparked an interest in breastmilk stem cell research 
across the world.  
Other teams worked to define the characteristics of breastmilk stem cells and Fan and 
colleagues also described these cells’ potential for self-renewal and differentiation through the 
identification of  various stem cell marker types .21 Indumathi and colleagues found that there 
were varying amounts of different stem cells within breastmilk23. Additionally, their findings 
differed from other teams in that their samples had limited numbers of mesenchymal stem cells 
(a type of  multipotent stem cell derived from the mesoderm that can differentiate to a variety of 
cell lines such as those found in tissue of the umbilical cord12), and a large number of 
hematopoietic  stem cells, which are the cells that produce all blood cell lines.  
Breastmilk Stem Cells Can Differentiate into all Three Germ Layers 
Once it was established that stem cells were present in breastmilk, researchers began to 
characterize these cells. Patki et al. were the first team to successfully differentiate breastmilk 
stem cells into different cell lines.30 They were able to differentiate these stem cells into 
adipogenic (fat), chondrogenic (cartilage), and osteogenic (bone) lineages. They also began to 
characterize the presence of stem cells in breastmilk and found that 10-15% of cells in breastmilk 
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are stem-like and that this number increases significantly after time in culture. These researchers 
confirmed that breastmilk stem cells in their study were mesenchymal, and as such, have the 
potential to be differentiated and used in regenerative medicine. These scientists also suggested 
that breastfeeding, by its very nature, is a stem cell therapy. Specifically, they hypothesized that 
breastmilk stem cells are ingested by the infant and have the ability to interact with the infant’s 
normal cells, influencing their development. See Figure 3 for our model which helps show the 
theorized method of stem cell dispersion throughout the body after ingestion. 
Additionally, Hosseini and colleagues’ (2014) findings support these results when they 
found that breastmilk stem cells expressed both mesenchymal and embryonic stem cells markers, 
and were differentiated into the three neural lineages (Oligodendrocytes, astrocytes, and 
neurons), which provides promise for further understanding on how breastmilk positively affects 
neurodevelopment.31 This research team also described the presence of hESC markers that were 
common among other research study findings (e.g. TRA-1-60, NANOG, OCT4), but unlike 
some of the prior studies, they did not find expression of a marker commonly associated with 
hESCs (SSEA1/4).24 This research team was also able to differentiate the breastmilk stem cells 
into both osteogenic (bone) and adipogenic (fat) lineages. 
The team from the University of Western Australia (Hassiotou e al., 2012) also found that 
breastmilk stem cells express similar genes to that of pluripotent human embryonic stem cells 
(hESCs). 19 Additionally, they were able to differentiate the stem cells into the three germ layers, 
which is characteristic of pluripotency. Yet, despite these findings, they were unable to form 
tumors in immunocompromised mice (teratoma assays), which is the standard to prove 
pluripotency19. However, the authors recognize that studies of other adult cells with pluripotent 
features sometimes do not form teratomas, but are still able to differentiate into damaged tissue. 
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They propose that this characteristic is positive and indicates that these cells have good potential 
for use in regenerative medicine (due to the fact they will not form tumors).  
Breastmilk Stem Cells Have Increased Levels of Pluripotent Genes Compared to the 
Resting Breast 
Hassiotou and colleagues has also specifically focused on breast cancer and examined 
breastmilk cells as a comparison of stem cell gene expression.32 Both breastmilk stem cells and 
breast tumors had up regulated expression of pluripotency genes when compared to the resting 
(non-lactating) breast. Markers associated with pluripotent characteristics of hESCs were highest 
in a mother who was pregnant when she provided breastmilk samples. They also found variation 
in expression levels between mothers and proposed that the variation may be due to the stage of 
lactation. 
Breastmilk Gene Expression Varies by Infant and Maternal Characteristics 
In the most recent study, researchers began to examine the variation in breastmilk stem 
cells between mothers.33 Twigger and colleagues found that the gene expression of stem cell 
markers is different dependent on some maternal and infant characteristics. One difference was 
in the expression of some markers between mothers with infants born at earlier gestational ages 
when compared to mothers whose infants were born at a later gestational age. Researchers 
hypothesized this finding might help explain why some mothers of preterm infants have low 
milk supply (i.e. decreased expression of stem cell markers may mean reduced function of the 
lactating breast).33 Additionally, increased maternal BMI was correlated with lower expression 
of a stem cell marker that is associated epithelial tissue (i.e. lactocytes, possibly explaining low 
milk supply with maternal obesity). Larger changes in maternal bra cup size from pre-pregnancy 
were correlated with higher expression of epithelial cell markers. This study was the first to 
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address the differences in stem cell gene expression between women, and also was the first to 
identify any specifics on the infants (which included gestational age at birth and infant gender). 
This study was the first to include mothers of preterm infants, However, it was not clear at what 
stage of lactation breastmilk collection occurred in relation to preterm birth (median infant age at 
time of collection was 30.5 weeks after birth—i.e. the infant was over 7 months old at time of 
breastmilk collection), or specifically how many mothers with preterm infants were included 
(age range of infants was 27.1 - 43.4 weeks gestation with a median of 39.3).33    
  Across all of these studies, there were differences in total cell counts in each mother’s 
breastmilk, and in expression of stem cell and cell markers.13,19,21,23,32,33 Not all studies identified 
the sample size or at what stage of lactation women were at when breastmilk collection occurred. 
Additionally, even though sample sizes seemed adequately large, it is important to note that for 
some of the analysis methods, only a very small number were analyzed (i.e. as noted in Table 2 
with methods such as flow cytometry). As suggested by Hassiotou et al, the differential 
expression of stem cell genes may be related to stage of lactation and being so, this information 
is important for future studies to address and report.32 Additionally, besides the publication by 
Twigger et al33, none of the studies report characteristics of the women who provided breastmilk, 
or characteristics of their breastfeeding infant.  
Stem Cells in Preterm Breastmilk 
Our team is currently the first known team in the world to investigate breastmilk stem 
cells from mothers of hospitalized preterm infants.34 Current research is focused on identifying 
differences in breastmilk for preterm and full-term infants within the first few weeks of birth. We 
have established feasibility of recruitment within the intensive care setting and collected specific 
health information from the infants and mothers to address the gaps in what has previously been 
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reported on the participants in this field of research. Current data analyses support that preterm 
breastmilk stem cells are variable between mothers similar to the variability in the full-term 
mother-infant dyad.35  
Discussion 
Implications for Practice 
The benefits of breastmilk are well reported in the literature; however, there is much to 
learn about breastmilk stem cells. As new evidence develops on the presence of stem cells within 
breastmilk, it will be important for healthcare professionals to be aware of their presence and to 
understand their potential impact on infant health. Preterm infants are born before achieving full 
gestation and typical growth after delivery is different from growth that would have occurred 
during gestation. In addition to the already known benefits of breastmilk, breastmilk stem cells 
may be contributing to improved growth and development in preterm infants.  
Implications for Research 
Breastmilk stem cells were first identified in 2007, and there remains a vast need for 
extensive research to further characterize their presence in all breastmilk (full-term and preterm), 
throughout the stages of lactation, and most importantly, their role in promoting and protecting 
the health of all infants. Due to the paucity of research in this area, there is much to be done in 
the coming years. Our research team is currently addressing the gap in literature focused 
specifically on the preterm infant and beginning to address questions related to the influence of 
breastmilk stem cells on infant health. Exciting work from the University of Western Australia 
shows through mouse models that breastmilk stem cells survive the neonatal gut and can be 
found as differentiated cells throughout the mouse pup’s body.28 The mechanism surrounding 
this expansion is still unknown and has the potential to advance scientific understanding and 
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facilitate future research endeavors focused on improving infant health. As more information is 
uncovered on breastmilk stem cells, we can begin to answer newly formed questions: When 
breastmilk stem cells are ingested, how are they involved with growth and development? More 
specifically, are they able to target vulnerable areas of the body (i.e. for the preterm infant, the 
gastrointestinal system, lungs, and brain)? How do NICU practices (e.g. refrigeration/ freezing/ 
warming) impact breastmilk stem cell viability and impact? Can breastmilk stem cells be used as 
a source for stem cell therapy (in the infant/in others)? Additionally, the beneficial properties of 
pluripotent stem cells are often used in the laboratory for a variety of research.  As mentioned 
previously, the human embryonic stem cell is the most versatile type, yet there is controversy of 
their use. An easily accessible pluripotent-characteristic stem cell from breastmilk may promise 
potential avenues for all research involving stem cells.  
Conclusion 
 The discovery of breastmilk stem cells has launched a new direction for breastmilk 
research which has begun to explain in greater detail the beneficial properties of breastmilk. The 
potential of breastmilk stem cells to explain some of the short and long term benefits of 
breastmilk ingestion in early life promises new trajectories of research that may expand the 
future use of breastmilk. To date, research has focused on further characterizing the stem cells in 
breastmilk and has yet to further delve into the exact mechanism of action that occurs when 
ingested by an infant. In the future, research will likely begin to focus on the therapeutic 
potential of these stem cells both when consumed naturally, and after being manipulated in the 
laboratory.  
 




Figure 1. Study Selection Process 
Figure 2. Breastmilk Stem Cell Research over Time 
Figure 3. Breastmilk stem cells spread throughout the infant’s body after ingestion where they 
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